Indication
Invasive Pneumococcal Disease
2 clinical trials
2 products
Clinical trial
A Randomized Controlled Trial to Compare a 1-dose vs. 2-dose Priming Schedule of 13-valent Pneumococcal Conjugate Vaccine in Canadian Infants; a Canadian Immunization Research Network (CIRN) StudyStatus: Completed, Estimated PCD: 2023-03-31
Product
PCV13Clinical trial
The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines (PCV10 and PCV13) on Immunogenicity and Vaccine-serotype Carriage in Kenyan InfantsStatus: Active (not recruiting), Estimated PCD: 2022-09-30
Product
PCV10